Cupabimod

[1]Tomita N, Morishita R, Lan HY, et al. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2000;11 (7) :1244-1252.|[2]Bruder SP, Affrime M, An H, et al. NF-kappa B Oligo DNA decoy provides 12 months of pain relief and disc height restoration for patients with chronic discogenic low back pain-a randomized clinical trial. Spine J. 2025;25 (11) :2391-2400.